(Q44119608)

English

Rapid quantitation of globotriaosylceramide in human plasma and urine: a potential application for monitoring enzyme replacement therapy in Anderson-Fabry disease

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Rapid quantitation of globotriaosylceramide in human plasma and urine: a potential application for monitoring enzyme replacement therapy in Anderson-Fabry disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

enzyme replacement therapy

0 references

1 reference

based on heuristic

inferred from title

Gianluca Bartolucci

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Francesca Boscaro

object named as

Francesca Boscaro

1

0 references

Giuseppe Pieraccini

object named as

Giuseppe Pieraccini

2

0 references

Cristina Luceri

object named as

Cristina Luceri

5

0 references

Giancarlo la Marca

object named as

Giancarlo la Marca

3

0 references

author name string

Francesca Luceri

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Gloriano Moneti

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Rapid Communications in Mass Spectrometry

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1507-1514

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males

1 reference

https://api.crossref.org/works/10.1002%2FRCM.728

21 January 2018

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females

1 reference

https://api.crossref.org/works/10.1002%2FRCM.728

21 January 2018

A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies

1 reference

https://api.crossref.org/works/10.1002%2FRCM.728

21 January 2018

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.728

21 January 2018

Ionization and fragmentation of neutral and acidic glycosphingolipids with a Q-TOF mass spectrometer fitted with a MALDI ion source

1 reference

https://api.crossref.org/works/10.1002%2FRCM.728

21 January 2018

Identifiers

10.1002/RCM.728

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44119608&oldid=2106780715"